Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases. - Wikidata - awgldk - TriplyDB

Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases.

Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases.

http://www.wikidata.org/entity/Q36227994

about

Crystal structure of human CD1e reveals a groove suited for lipid-exchange processes Humans lack iGb3 due to the absence of functional iGb3-synthase: implications for NKT cell development and transplantation Globosides but not isoglobosides can impact the development of invariant NKT cells and their interaction with dendritic cells Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans Linking inflammation to natural killer T cell activation.Lysosomal alpha-galactosidase controls the generation of self lipid antigens for natural killer T cells Thymic alterations in GM2 gangliosidoses model mice.Inhibition of endocytic lipid antigen presentation by common lipophilic environmental pollutants.Lipid and glycolipid antigens of CD1d-restricted natural killer T cells.Antigen-dependent versus -independent activation of invariant NKT cells during infection Multi-system disorders of glycosphingolipid and ganglioside metabolism Lipid antigens in immunity.Invariant NKT cell development requires a full complement of functional CD3 zeta immunoreceptor tyrosine-based activation motifs Development of spontaneous anergy in invariant natural killer T cells in a mouse model of dyslipidemia.Transcriptional control of invariant NKT cell development.Gaucher's disease and cancer: a sphingolipid perspective iNKT cell autoreactivity: what is 'self' and how is it recognized?Essential role for autophagy during invariant NKT cell development.Diverse endogenous antigens for mouse NKT cells: self-antigens that are not glycosphingolipids.Identification of self-lipids presented by CD1c and CD1d proteins.Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals Natural killer T cells: know thyself.Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammals Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency.Innate and Adaptive Immune Response in Fabry Disease Neuronal and epithelial cell rescue resolves chronic systemic inflammation in the lipid storage disorder Niemann-Pick C.Chewing the fat on natural killer T cell development.The Niemann-Pick type C2 protein loads isoglobotrihexosylceramide onto CD1d molecules and contributes to the thymic selection of NKT cells.Invariant natural killer T cells are not affected by lysosomal storage in patients with Niemann-Pick disease type C.Scavenger receptors target glycolipids for natural killer T cell activation.Role for lysosomal phospholipase A2 in iNKT cell-mediated CD1d recognition.Immune dysfunction in Niemann-Pick disease type C.CD1d-restricted iNKT cells, the 'Swiss-Army knife' of the immune system.CD1d presentation of glycolipids.CD1d-restricted glycolipid antigens: presentation principles, recognition logic and functional consequences.Immunologic glycosphingolipidomics and NKT cell development in mouse thymus.The immunological functions of saposins.The dangerous liaison between iNKT cells and dendritic cells: does it prevent or promote autoimmune diseases?Treating inflammation in childhood neurodegenerative disorders.NKT cell ligand recognition logic: molecular basis for a synaptic duet and transmission of inflammatory effectors.

P2860

Q27671006-AE47327A-D6BF-4BB0-8DF2-BEFDE4EDC38B Q28119060-BCF60EB4-89FF-42DC-84FC-E9D102B61ABD Q28505051-078D3620-8C43-4903-8555-D8A8F89CD87C Q28511526-A845673B-C5C4-4B26-ABC8-679812ECE505 Q33512902-E11628FC-CD1C-4910-AD7C-E5CE900D2A34 Q33599438-D46D105A-4419-4162-B05C-3632F255779D Q33697973-F197B101-F863-46F3-9E2E-7A78D4499FA2 Q33704671-E8796191-2415-4F1B-825B-511DE73E4267 Q33724575-2D81651D-E147-4FA5-9A2F-5CE282107897 Q33741015-50217D11-B0A3-40AD-BB2E-F61DB5013CBB Q33902037-DA560406-DBDF-4674-A4B2-72A17F3D65E1 Q34025822-59A85682-CD24-46E5-8D63-6DAB5B16F659 Q34162876-2354F261-1446-4D86-8943-D45B1F063C9F Q34235221-49F8FBD5-3878-4605-A04C-10E9F957EA7F Q34248566-004F36F2-36C9-4202-8C16-48C0CD12398C Q34333982-9A6D281A-DC9E-4A46-9540-E70F06B3A195 Q34760309-5A4FA410-67A1-4E59-A3D9-6837A58554EB Q34831651-B3E460CC-B919-40CC-B26A-1BE183282C5C Q35195374-CE933253-1C3E-4C2B-82EC-4131FB49FD68 Q35424025-26CE96A6-296C-468C-B02A-3857614D2AC0 Q35622939-C78CD7D6-A9DE-4909-93E8-628CDBA9CD69 Q35749476-A59162B1-E6D9-45E6-B7FA-294ACE733C9E Q35749602-835CCCF8-A174-4F59-ACB5-BC76C32752A3 Q35749606-FEF3E216-2983-4D65-B10A-F4234D848EC3 Q35800976-92BDDD60-C251-4B97-B432-8E24507D973A Q36026905-00DF5975-CD67-4C76-A131-CF39B7DE9DEF Q36227953-BFF2D422-D521-4011-B459-69B712C58250 Q36229257-F75026B2-53BE-40B0-8868-4F1173CE53E8 Q36288508-BB762167-2994-4FBE-B4E1-55AE84296D56 Q36357825-1BE3BE2B-415C-4641-B3E0-AF46AFEF8443 Q36729593-5D78AF8F-DE4E-4F6B-8625-C2E7045FA8CC Q36802183-ABFC62B9-5C5B-41A6-A33F-E1DE0ABA3636 Q36898124-FCC1DE75-91E0-4F26-9C5F-25F26D58625F Q37187358-78123BF4-F513-4F29-9FA8-242C13AEEB95 Q37207409-4435321E-0770-49BD-B86D-8A5AB377D56E Q37287214-87D6DC82-9B81-4DA4-A912-1966E4D4C97E Q37761491-8693E60B-F8B2-4C2D-9909-97D5E43A6E21 Q37776696-9C1A58C4-A914-4E98-A50B-CC92CED73014 Q37839130-B4E34BA0-FD9A-41D2-826B-F75D1EAE9B61 Q37902828-46588682-8663-48DB-B642-B458A8FB4F2D

P2860

Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases.

http://www.wikidata.org/entity/Q36227994

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Impaired selection of invarian ...... id lysosomal storage diseases.

@ast

Impaired selection of invarian ...... id lysosomal storage diseases.

@en

type

label

Impaired selection of invarian ...... id lysosomal storage diseases.

@ast

Impaired selection of invarian ...... id lysosomal storage diseases.

@en

prefLabel

Impaired selection of invarian ...... id lysosomal storage diseases.

@ast

Impaired selection of invarian ...... id lysosomal storage diseases.

@en

P1433

Q36227994-D17E4DEF-05A1-4960-995C-BB2FA1E5B497

P1476

Q36227994-6820027A-18F2-478B-BE08-EAB736BBAD61

P2093

Q36227994-218A13CB-935C-4711-B934-628A8B0F103A

Q36227994-224CC16C-8D9E-4C02-9C8F-ACC80E9719A7

Q36227994-271118FC-9AA0-4B85-BCDF-6556CC20686E

Q36227994-49338594-3D26-4965-A697-58D0AEFB2EAD

Q36227994-B828BF08-A65D-4FF8-B0C2-442B2516DF31

P2860

Q36227994-0D2E4FD3-3819-4078-9CA9-F2ECF9F79B3D

Q36227994-11E42305-7AC3-4016-8964-08C2A7827AF7

Q36227994-20462A2F-CC61-46A4-BA28-52AE6737B44A

Q36227994-21CA45DC-4774-41DE-AE75-7D24028027C9

Q36227994-236079B5-D1DF-4AE6-BF75-3939BC610A27

Q36227994-2D5D9CCA-CC48-4BEB-97E9-20D21C8BA7AF

Q36227994-354DD974-6E55-41FA-97BB-40420C6A1FBB

Q36227994-366333C9-291A-4A0E-97CD-CD2E96D62A93

Q36227994-370C8DCE-91B0-4B71-BD46-7766538289B4

Q36227994-45D2037F-3917-4860-A40C-49100D4BC60F

P304

Q36227994-15712859-7C72-45FE-9FAF-DE50FD1390CB

P31

Q36227994-9E730977-B6C4-4F12-B08A-DDA6A9C119BE

P356

Q36227994-B2EE0499-65F5-4563-B9E7-D98220412698

P407

Q36227994-B9AED22F-49AF-4384-B04B-4AC9D2C7AB8E

P433

Q36227994-2A321AA3-DE36-4C9B-9015-B5DFA7EA1E7A

P478

Q36227994-D31BA1D4-0659-4B79-8A08-8B5F11BDECA3

P50

Q36227994-00B536F9-9D4D-4318-A962-7004184EC8A5

Q36227994-0F1554B4-633C-4B19-9117-1D4244F17620

Q36227994-613DC41C-C12A-4891-A93B-B0B6E87EA21E

Q36227994-95943BA6-7DF7-4F18-9992-0843F2A78BBD

Q36227994-D057A544-00BD-47DE-8DE8-BE5717D37862

P577

Q36227994-8DFC5EB7-1D81-4552-912E-E7FDD5EE2FE8

P5875

Q36227994-A8B16F7D-B4BA-4C6A-806B-EEFE7AA06CF5

P698

Q36227994-309947F2-4BAF-4E2B-B5E8-5D8E1BD56323

P932

Q36227994-366EB494-C24F-48A0-9A60-C7B34EA9C89F

P356

P1433

Journal of Experimental Medicine

P1476

Impaired selection of invarian ...... id lysosomal storage diseases.

@en

P2093

Aruna Jeans

http://www.w3.org/2001/XMLSchema#string

Petr A Illarionov

http://www.w3.org/2001/XMLSchema#string

Raymond Dwek

http://www.w3.org/2001/XMLSchema#string

Stephan D Gadola

http://www.w3.org/2001/XMLSchema#string

Terry D Butters

http://www.w3.org/2001/XMLSchema#string

P2860

Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules

The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo

CD1: antigen presentation and T cell function

NKT cells derive from double-positive thymocytes that are positively selected by CD1d

alpha-Galactosidase A deficient mice: a model of Fabry disease

CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain

Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease

Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis

CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4

Glycolipid antigen processing for presentation by CD1d molecules.

P304

2293-2303

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20060921

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

203

http://www.w3.org/2001/XMLSchema#string

P50

Vincenzo Cerundolo

Mariolina Salio

Jonathan D Silk

P577

2006-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6811157

http://www.w3.org/2001/XMLSchema#string

P698

16982810

http://www.w3.org/2001/XMLSchema#string

P932

2118110

http://www.w3.org/2001/XMLSchema#string